Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Accelagen logo — company profile

Accelagen

Founded 2007 7 employees Biotechnology, Health Care

General Information

Company Name Accelagen
Founded Year 2007
Employees 7
Industries Biotechnology, Health Care
Social

Get notified when Accelagen moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Accelagen

Accelagen is a rapidly expanding player in the biotechnology and healthcare industries. Founded in 2007, the company specializes in gene-to-protein services, utilizing advanced technologies such as Baculovirus Expression Vector System (BEVS), E. coli expression, mammalian expression, Wave Bioreactors, Cell Factory, and AKTA chromatography systems. This integrated platform enables Accelagen to deliver high-quality proteins, while significantly expediting the processes from gene to protein. Despite not having specific data on their headquarter or recent investment activities, Accelagen's innovative approach and strong foothold in the biotech and healthcare sectors make it an intriguing prospect for venture capitalists seeking to capitalize on the burgeoning demand for advanced protein production technologies.

Taxonomy: Gene-to-Protein, Baculovirus Expression Vector System, Protein Production, Bioreactors, Chromatography, Protein Quality, Mammalian Expression, E. coli Expression, Cell Factory, Biopharmaceuticals, Protein Engineering, Bioprocessing, Research and Development, Biotech Startups

No funding data available for Accelagen yet.

Get notified when Accelagen raises funding

Accelagen Alternatives & Competitors

Accelagen vs
Applied Genomics
Applied Genomics

Innovative tools for advanced cancer detection and classification through comprehensive gene and pro...

Biotechnology
Accelagen vs
Takara Bio USA, Inc.
Takara Bio USA, Inc. United States

Empowering gene and cell therapy with comprehensive manufacturing and customer services.

296 employees
Biotechnology
Accelagen vs
Genekine
Genekine

Pioneering advancements in macromolecular drugs through innovative protein expression and genetic en...

Undisclosed
Biotechnology, Health Care

FAQ About Accelagen

Accelagen is a fast growing Gene-to-Protein company. Accelagen’s gene-to-protein platform integrates the latest technologies of Baculovirus Expression Vector System (BEVS), E. coli expression, mammalian expression, Wave Bioreactors, Cell Factory, and AKTA chromatography systems, providing superior p...
Accelagen was founded in 2007.
Accelagen operates in the following industries: Biotechnology, Health Care.
Accelagen has approximately 7 employees.
Top alternatives and competitors to Accelagen include Applied Genomics, Takara Bio USA, Inc., Genekine, Vectron Biosolutions AS, Proteos. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Accelagen and Applied Genomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Accelagen and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy